Adaptix secures US federal route for portable 3D imaging

Avingtrans plc

Avingtrans subsidiary Adaptix has appointed Spartan Medical as the exclusive US federal government reseller of its Ortho350 portable 3D imaging system.

The agreement gives Adaptix a direct route into Department of Veterans Affairs medical centres, military treatment facilities and other federal healthcare organisations.

Spartan Medical is a Service-Disabled Veteran-Owned Small Business with experience in federal healthcare procurement. Its role is to support access to a market where purchasing processes can be complex and sales cycles can be long. Using an established federal reseller reduces the need for Adaptix to build its own government sales infrastructure. It also gives the company a partner that understands the requirements of Veterans Affairs and Department of Defense facilities.

The Ortho350 is designed to provide 3D orthopaedic imaging at the point of care. It can produce CT-style images in an examination room in under 20 seconds, using a radiation dose comparable with conventional plain-film imaging.

This allows clinicians to access more detailed images without sending patients to a separate CT facility. The system may be useful in locations where space, cost or infrastructure limits access to conventional scanners.

Adaptix uses low-dose tomosynthesis technology to create high-resolution 3D images of bone structures and soft tissue. The company says the system can improve diagnostic visibility while reducing radiation exposure and operating costs compared with traditional CT imaging.

Avingtrans plc (LON:AVG) has a proven strategy of “buy and build” in highly regulated engineering markets, a strategy it has named “Pinpoint-Invest-Exit”. 

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Avingtrans CEO Steve McQuillan on record revenue, nuclear demand and medical imaging progress

Avingtrans plc (LON: AVG) CEO Steve McQuillan discusses record revenue of £163 million, adjusted EBITDA exceeding £20 million, a strong order book and growing demand for nuclear engineering products.

Avingtrans plc: Record £163m Revenue, 90% Order Cover and Adaptix Nears Commercial Breakthrough

Avingtrans CEO Steve McQuillan discusses record £163m revenue, more than 90% order coverage and growing nuclear opportunities, while Adaptix moves from regulatory approvals towards commercial orthopaedic sales.

Avingtrans reports record revenue and strong profit growth as AI and nuclear demand builds

Avingtrans reported record revenue of £163.3m for FY2026, with adjusted EBITDA rising 24% to £20.7m as strong demand across AI infrastructure, data centres, electrification and nuclear power supported growth.

Avingtrans acquires US nuclear specialist Joseph Oat for $2.5m

Avingtrans has acquired the intellectual property, trading history and brand of US nuclear engineering specialist Joseph Oat for $2.5m, expanding its nuclear capabilities and access to legacy equipment across the US power sector.

Adaptix expands US distribution with Digital X-Ray Technologies partnership

Adaptix has appointed Digital X-Ray Technologies as a US distributor for the Ortho350, expanding access to its 3D orthopaedic imaging system across the West Coast and Pacific Islands.

Booth Industries strengthens infrastructure credentials with completed Silvertown Tunnel project

Booth Industries completed a circa £1.3 million Silvertown Tunnel contract in 2024, supplying and installing 25 specialist fire and pressure-resistant doorsets.

Search